BiomeBank today announced the opening of its new GMP manufacturing facility designed to increase global supply of its approved donor derived microbiome-based therapy and further develop its second-generation therapies.
BiomeBank has announced the appointment of Kolby Day to the new position of Chief Operating Officer at the biotech drug development company based in Adelaide, South Australia.
Formal Therapeutic Goods Administration (“TGA”) approval of BiomeBank’s first-generation donor derived microbiome-based therapy.
Page Contents Overview The human body is inhabited by trillions of microscopic organisms including bacteria, viruses, fungi and archaea. Although they’re too small to see with the naked eye, microbes inhabit almost every part of the human body, including on our skin, up our nose and inside our gut. Collectively…
The translation of research into the development of innovative and life-saving microbial therapies is set to transform in Australia through a partnership between Hudson Institute of Medical Research and BiomeBank, a clinical stage microbiome therapeutics company.
BiomeBank appoints Mr Chris Hall as Chair, effective 17 January 2022. Mr Hall brings over 30 years’ experience and impressive track record of investment management across both public and private markets within APAC. BiomeBank’s Series A funding round anticipated to close in early 2022. Formal Therapeutic Goods Association (“TGA”) approval of…
Super poo: the emerging science of stool transplants and designer gut bacteria As more people turn to faecal transplants for their health benefits, researchers in Adelaide are harnessing the power of high-quality poo in new treatments that can simply be swallowed
ADELAIDE, South Australia--(BUSINESS WIRE)The company behind Australia’s first facility for the manufacturing of microbial therapies has set its sights on global impact, applying to the Therapeutic Goods Administration, Australia’s regulatory authority, for approval of their world-first biologic drug product.“In addition to our existing syringe-based therapy, we are also developing capsule based-products that will allow improved patient…
Revolutionary faecal transplants are the latest new treatment option being trialled in people living with Parkinson’s to help manage their debilitating symptoms by replenishing their healthy gut bacteria.